IDEAYA Biosciences Statistics
Total Valuation
IDYA has a market cap or net worth of $3.44 billion. The enterprise value is $2.74 billion.
| Market Cap | 3.44B |
| Enterprise Value | 2.74B |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IDYA has 84.04 million shares outstanding. The number of shares has increased by 55.28% in one year.
| Shares Outstanding | 84.04M |
| Shares Change (YoY) | +55.28% |
| Shares Change (QoQ) | +14.97% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 99.03% |
| Float | 74.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 4.65 |
| PS Ratio | 221.65 |
| Forward PS | n/a |
| PB Ratio | 3.67 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 176.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.42, with a Debt / Equity ratio of 0.00.
| Current Ratio | 28.42 |
| Quick Ratio | 28.03 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.10% and return on invested capital (ROIC) is -16.97%.
| Return on Equity (ROE) | -20.10% |
| Return on Assets (ROA) | -19.30% |
| Return on Capital (ROIC) | -16.97% |
| Revenue Per Employee | $125,032 |
| Profits Per Employee | -$1.04M |
| Employee Count | 124 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +88.69% in the last 52 weeks. The beta is 0.86, so IDYA's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +88.69% |
| 50-Day Moving Average | 38.54 |
| 200-Day Moving Average | 37.56 |
| Relative Strength Index (RSI) | 57.66 |
| Average Volume (20 Days) | 1,449,721 |
Short Selling Information
The latest short interest is 11.71 million, so 13.93% of the outstanding shares have been sold short.
| Short Interest | 11.71M |
| Short Previous Month | 11.04M |
| Short % of Shares Out | 13.93% |
| Short % of Float | 15.64% |
| Short Ratio (days to cover) | 11.57 |
Income Statement
In the last 12 months, IDYA had revenue of $15.50 million and -$128.89 million in losses. Loss per share was -$2.01.
| Revenue | 15.50M |
| Gross Profit | 15.50M |
| Operating Income | -159.17M |
| Pretax Income | -128.89M |
| Net Income | -128.89M |
| EBITDA | -124.76M |
| EBIT | -128.89M |
| Loss Per Share | -$2.01 |
Balance Sheet
The company has $699.53 million in cash and $2.41 million in debt, giving a net cash position of $697.12 million or $8.29 per share.
| Cash & Cash Equivalents | 699.53M |
| Total Debt | 2.41M |
| Net Cash | 697.12M |
| Net Cash Per Share | $8.29 |
| Equity (Book Value) | 935.31M |
| Book Value Per Share | 11.13 |
| Working Capital | 684.39M |
Cash Flow
In the last 12 months, operating cash flow was -$131.20 million and capital expenditures -$3.65 million, giving a free cash flow of -$134.85 million.
| Operating Cash Flow | -131.20M |
| Capital Expenditures | -3.65M |
| Free Cash Flow | -134.85M |
| FCF Per Share | -$1.80 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,026.63% and -831.35%.
| Gross Margin | 100.00% |
| Operating Margin | -1,026.63% |
| Pretax Margin | -831.35% |
| Profit Margin | -831.35% |
| EBITDA Margin | -804.71% |
| EBIT Margin | -831.35% |
| FCF Margin | -869.74% |
Dividends & Yields
IDYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -55.28% |
| Shareholder Yield | -55.28% |
| Earnings Yield | -3.75% |
| FCF Yield | -3.92% |
Analyst Forecast
The average price target for IDYA is $54.55, which is 33.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.55 |
| Price Target Difference | 33.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 98.24% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDYA has an Altman Z-Score of 78.51 and a Piotroski F-Score of 1.
| Altman Z-Score | 78.51 |
| Piotroski F-Score | 1 |